Hypotension After Spinal Anesthesia

4

Review clinical trials related to Hypotension After Spinal Anesthesia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

ED50/ED90 of Phenylephrine Infusion for Preventing Spinal Anesthesia-Induced Hypotension: Supine vs Left-Tilt 15°

The purpose of this study is to determine the 50% and 90% effective doses (ED50 and ED90) of prophylactic phenylephrine infusion for preventing spinal anesthesia-induced hypotension during elective cesarean delivery, in the supine position and in the left-lateral-tilt 15° position, respectively. Two hundred parturients with singleton term pregnancies will be randomized 1:1 to the supine group or the left-tilt 15° group, and within each position 1:1:1:1 to one of four fixed phenylephrine infusion rates (0.2, 0.4, 0.6, or 0.8 μg/kg/min; 25 per group), with the rate allocation masked by concentration blinding (identical pump rate, different solution concentrations). Spinal anesthesia consists of hyperbaric bupivacaine 12 mg plus morphine 0.15 mg. The primary outcome is the incidence of hypotension (systolic blood pressure \< 80% of baseline or \< 90 mmHg) from completion of the intrathecal injection to delivery. ED50 and ED90 will be estimated by probit regression within each position.

Participants needed: 200
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: Peking University People's HospitalUpdated: Sep 17, 2026Locations: 1
Eligibility criteria

Singleton term pregnancy scheduled for elective cesarean delivery [+3]

Transverse lie or suspected macrosomia [+8]

Status: Not yet recruiting

Comparison of Hypotension After Spinal Anesthesia With Hyperbaric Vs Isobaric Bupivacaine in Elective Cesarean After Colloid Preloading.

To assess the hemodynamic difference after spinal anesthesia with hyperbaric bupivacaine and isobaric bupivacaine in elective cesarean section

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Liaquat National Hospital & Medical CollegeUpdated: Feb 17, 2026Locations: 1
Eligibility criteria

ASA II parturient with normal pregnancy Parturients undergoing elective cesarean...

Patient refusal Parturient with known drug allergy to local anesthetics Parturie...

Status: Not yet recruiting

Comparison of the Efficacy of Continuous Metaraminol Infusion Versus Continuous Norepinephrine Infusion for the Prevention of Hypotension During Cesarean Section Under Spinal Anaesthesia. A Randomised Controlled Trial.

The aim of this double-blind randomised study will be to compare a fixed-rate prophylactic metaraminol infusion to a fixed-rate prophylactic norepinephrine infusion during elective cesarean section under combined spinal-epidural anaesthesia.

Participants needed: 80
Trial details
Age: 18-48Biological sex: FemaleType: InterventionalSponsor: Aretaieion University HospitalUpdated: Jan 23, 2026
Eligibility criteria

Not listed

Status: Not yet recruiting

Preoperative Oral Heptaminol Hydrochloride in Preventing Hypotension After Spinal Anesthesia

Methodologies and approaches have been implemented with differing degrees of success to prevent neuraxial hypotension. Currently utilized approaches to prevent hypotension during spinal anesthetic administration consist of physical precautions such as leg restraints and compression hosiery, as well as sympathomimetic medications Through a competitive inhibition of noradrenaline uptake, heptaminol hydrochloride prevented orthostatic hypotension and increased the plasma concentration of noradrenaline. This inhibitory effect might account for a portion of the antihypotensive effect After thorough research of the literature, studies evaluating the role of preoperative oral heptaminol hydrochloride in preventing hypotension after spinal anesthesia in lower limb surgeries with tourniquets are lacking.

Participants needed: 160
Trial details
Phase: Phase 3Age: 18-50Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: Aug 21, 2024
Eligibility criteria

Age from 18 to 50 years old. [+3]

Patient refusal. [+9]